News Releases Year None202220212020201920182017 NuCana to Participate in the 7th Annual Truist Securities Life Sciences Summit Apr 28, 2021 NuCana Announces Five Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021 Apr 10, 2021 NuCana Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Business Update Mar 04, 2021 NuCana to Participate in Three Upcoming Investor Conferences Feb 25, 2021 NuCana Presents Encouraging Data at ASCO GI for NUC-3373 in Heavily Pre-Treated Patients with Metastatic Colorectal Cancer Jan 15, 2021 NuCana Appoints Andrew Kay as Board Chairman Dec 21, 2020 Final Data from the Phase Ib Study of Acelarin plus Cisplatin in Patients with Advanced Biliary Tract Cancer Published Online Ahead of Print in The Oncologist Nov 30, 2020 NuCana Reports Third Quarter 2020 Financial Results and Provides Business Update Nov 19, 2020 NuCana to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference Nov 17, 2020 NuCana to Present at the Jefferies Virtual London Healthcare Conference Nov 12, 2020 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
NuCana Announces Five Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021 Apr 10, 2021
NuCana Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Business Update Mar 04, 2021
NuCana Presents Encouraging Data at ASCO GI for NUC-3373 in Heavily Pre-Treated Patients with Metastatic Colorectal Cancer Jan 15, 2021
Final Data from the Phase Ib Study of Acelarin plus Cisplatin in Patients with Advanced Biliary Tract Cancer Published Online Ahead of Print in The Oncologist Nov 30, 2020